© 1996 American Heart Association, Inc.
Articles |
Contribution of an In Vivo Oxidized LDL to LDL Oxidation and Its Association With Dense LDL Subpopulations
From the Department of Molecular Pharmacology and Toxicology (A.S., J.H., H.H.), School of Pharmacy, and the Atherosclerosis Research Unit (A.S., H.H.), Division of Cardiology, University of Southern California, Los Angeles, Calif, and the Centro Regionale Specializzato per l'Arteriosclerosi (G.C., G.B.-B.), Servizio di Diabetologia, Ospedale Riuniti, Venezia, Italy.
Correspondence to Alex Sevanian, University of Southern California, Department of Molecular Pharmacology and Toxicology, School of Pharmacy, 1985 Zonal Ave, PSC 612, Los Angeles, CA 90033.
Abstract Oxidative modification of LDL is thought to be a
radical-mediated process involving lipid peroxides. The small dense
LDL subpopulations are particularly susceptible to oxidation, and
individuals with high proportions of dense LDL are at a greater risk
for atherosclerosis. An oxidatively modified plasma
LDL, referred to as LDL-, is found largely
among the dense LDL fractions. LDL- and dense LDL
particles also contain much greater amounts of lipid peroxides compared
with total LDL or the more buoyant LDL fractions. The content of
LDL- in dense LDL particles appears to be related to
copper- or heme-induced oxidative susceptibility, which may be
attributable to peroxide levels. The rate of lipid peroxidation during
the antioxidant-protected phase (lag period) and the length of the
antioxidant-protected phase (lag time) are correlated with the
LDL- content of total LDL. Once LDL oxidation enters
the propagation phase, there is no relationship to the initial
LDL- content or total LDL lipid peroxide or vitamin E
levels. Beyond a threshold LDL- content of 
2%,
there is a significant increase in the oxidative susceptibility of nLDL
particles (ie, purified LDL that is free of LDL-),
and this susceptibility becomes more pronounced as the
LDL- content increases. nLDL is resistant to
copper- or heme-induced oxidation. The oxidative susceptibility is
not influenced by vitamin E content in LDL but is strongly inhibited by
ascorbic acid in the medium. Involvement of
LDL--associated peroxides during the stimulated
oxidation of LDL is suggested by the inhibition of nLDL oxidation when
LDL- is treated with ebselen prior to its addition to
nLDL. Populations of LDL enriched with LDL- appear to
contain peroxides at levels approaching the threshold required for
progressive radical propagation reactions. We postulate that elevated
LDL- may constitute a pro-oxidant state that
facilitates oxidative reactions in vascular components.
Key Words: lipid peroxidation • peroxides • ascorbic acid • heme
This article has been cited by other articles:
 |
|
 |
|
  S. Tsimikas, P. Clopton, E. S. Brilakis, S. M. Marcovina, A. Khera, E. R. Miller, J. A. de Lemos, and J. L. Witztum Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors: Results From the Dallas Heart Study Circulation, April 7, 2009; 119(13): 1711 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Parasassi, M. De Spirito, G. Mei, R. Brunelli, G. Greco, L. Lenzi, G. Maulucci, E. Nicolai, M. Papi, G. Arcovito, et al. Low density lipoprotein misfolding and amyloidogenesis FASEB J, July 1, 2008; 22(7): 2350 - 2356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Natella, M. Nardini, F. Belelli, and C. Scaccini Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans Am. J. Clinical Nutrition, September 1, 2007; 86(3): 604 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kanayama, S. Yamaguchi, T. Shibata, N. Shibata, M. Kobayashi, R. Nagai, H. Arai, K. Takahashi, and K. Uchida Identification of a Serum Component That Regulates Cyclooxygenase-2 Gene Expression in Cooperation with 4-Hydroxy-2-nonenal J. Biol. Chem., August 17, 2007; 282(33): 24166 - 24174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Gaubatz, B. K. Gillard, J. B. Massey, R. C. Hoogeveen, M. Huang, E. E. Lloyd, J. L. Raya, C.-y. Yang, and H. J. Pownall Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A2 J. Lipid Res., February 1, 2007; 48(2): 348 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-h. Chen, B. D. Hosken, M. Huang, J. W. Gaubatz, C. L. Myers, R. D. Macfarlane, H. J. Pownall, and C.-y. Yang Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic J. Lipid Res., January 1, 2007; 48(1): 177 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Asatryan, R. T. Hamilton, J. M. Isas, J. Hwang, R. Kayed, and A. Sevanian LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein J. Lipid Res., January 1, 2005; 46(1): 115 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hwang, M. H. Ing, A. Salazar, B. Lassegue, K. Griendling, M. Navab, A. Sevanian, and T. K. Hsiai Pulsatile Versus Oscillatory Shear Stress Regulates NADPH Oxidase Subunit Expression: Implication for Native LDL Oxidation Circ. Res., December 12, 2003; 93(12): 1225 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ziouzenkova, L. Asatryan, D. Sahady, G. Orasanu, S. Perrey, B. Cutak, T. Hassell, T. E. Akiyama, J. P. Berger, A. Sevanian, et al. Dual Roles for Lipolysis and Oxidation in Peroxisome Proliferation-Activator Receptor Responses to Electronegative Low Density Lipoprotein J. Biol. Chem., October 10, 2003; 278(41): 39874 - 39881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Asatryan, O. Ziouzenkova, R. Duncan, and A. Sevanian Heme and lipid peroxides in hemoglobin-modified low-density lipoprotein mediate cell survival and adaptation to oxidative stress Blood, September 1, 2003; 102(5): 1732 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Benitez, J. L. Sanchez-Quesada, V. Ribas, O. Jorba, F. Blanco-Vaca, F. Gonzalez-Sastre, and J. Ordonez-Llanos Platelet-Activating Factor Acetylhydrolase Is Mainly Associated With Electronegative Low-Density Lipoprotein Subfraction Circulation, July 8, 2003; 108(1): 92 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Sanchez-Quesada, S. Benitez, C. Otal, M. Franco, F. Blanco-Vaca, and J. Ordonez-Llanos Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects J. Lipid Res., May 1, 2002; 43(5): 699 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tanaga, H. Bujo, M. Inoue, K. Mikami, K. Kotani, K. Takahashi, T. Kanno, and Y. Saito Increased Circulating Malondialdehyde-Modified LDL Levels in Patients With Coronary Artery Diseases and Their Association With Peak Sizes of LDL Particles Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 662 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Sanchez-Quesada, A. Perez, A. Caixas, M. Rigla, A. Payes, S. Benitez, and J. Ordonez-Llanos Effect of Glycemic Optimization on Electronegative Low-Density Lipoprotein in Diabetes: Relation to Nonenzymatic Glycosylation and Oxidative Modification J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3243 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Hargrove, T. D. Etherton, T. A. Pearson, E. H. Harrison, and P. M. Kris-Etherton Low Fat and High Monounsaturated Fat Diets Decrease Human Low Density Lipoprotein Oxidative Susceptibility In Vitro J. Nutr., June 1, 2001; 131(6): 1758 - 1763. [Abstract] [Full Text]
|
|
|
|
|
|
S. Tsimikas and J. L. Witztum Measuring Circulating Oxidized Low-Density Lipoprotein to Evaluate Coronary Risk Circulation, April 17, 2001; 103(15): 1930 - 1932. [Full Text] [PDF]
|
|
|
|
|
|
W. Engelen, B. M. y Keenoy, J. Vertommen, and I. De Leeuw Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1142 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Conxita De Castellarnau, J. L. Sanchez-Quesada, S. Benitez, R. Rosa, L. Caveda, L. Vila, and J. Ordonez-Llanos Electronegative LDL From Normolipemic Subjects Induces IL-8 and Monocyte Chemotactic Protein Secretion by Human Endothelial Cells Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2281 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Morena, J.-P. Cristol, T. Dantoine, M.-A. Carbonneau, B. Descomps, and B. Canaud Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients Nephrol. Dial. Transplant., March 1, 2000; 15(3): 389 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sugano, S. Sawada, K. Tsuchida, N. Makino, and M. Kamada Low density lipoproteins develop resistance to oxidative modification due to inhibition of cholesteryl ester transfer protein by a monoclonal antibody J. Lipid Res., January 1, 2000; 41(1): 126 - 133. [Abstract] [Full Text]
|
|
|
|
|
|
S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ziouzenkova, L. Asatryan, M. Akmal, C. Tetta, M. L. Wratten, G. Loseto-Wich, G. Jurgens, J. Heinecke, and A. Sevanian Oxidative Cross-linking of ApoB100 and Hemoglobin Results in Low Density Lipoprotein Modification in Blood. RELEVANCE TO ATHEROGENESIS CAUSED BY HEMODIALYSIS J. Biol. Chem., July 2, 1999; 274(27): 18916 - 18924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Bielicki and T. M. Forte Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity J. Lipid Res., May 1, 1999; 40(5): 948 - 954. [Abstract] [Full Text]
|
|
|
|
|
|
G. Gardner, C. L. Banka, K. A. Roberts, A. E. Mullick, and J. C. Rutledge Modified LDL–Mediated Increases in Endothelial Layer Permeability Are Attenuated With 17ß-Estradiol Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 854 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jimi, N. Uesugi, K. Saku, H. Itabe, B. Zhang, K. Arakawa, and S. Takebayashi Possible Induction of Renal Dysfunction in Patients With Lecithin:Cholesterol Acyltransferase Deficiency by Oxidized Phosphatidylcholine in Glomeruli Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 794 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bittolo-Bon and G. Cazzolato Analytical capillary isotachophoresis of total plasma lipoproteins: a new tool to identify atherogenic low density lipoproteins J. Lipid Res., January 1, 1999; 40(1): 170 - 177. [Abstract] [Full Text]
|
|
|
|
|
|
B. Vedie, X. Jeunemaitre, J. L. Megnien, I. Myara, H. Trebeden, A. Simon, and N. Moatti Charge Heterogeneity of LDL in Asymptomatic Hypercholesterolemic Men Is Related to Lipid Parameters and Variations in the ApoB and CIII Genes Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1780 - 1789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Smalley, N. Hogg, B. Kalyanaraman, and K. A. Pritchard Jr Endothelial Cells Prevent Accumulation of Lipid Hydroperoxides in Low-Density Lipoprotein Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3469 - 3474. [Abstract] [Full Text]
|
|
|
|
|
|
K. Tanaga, H. Bujo, M. Inoue, K. Mikami, K. Kotani, K. Takahashi, T. Kanno, and Y. Saito Increased Circulating Malondialdehyde-Modified LDL Levels in Patients With Coronary Artery Diseases and Their Association With Peak Sizes of LDL Particles Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 662 - 666. [Abstract] [Full Text] [PDF]
|
|